RTTNews | Aug 27, 2020 04:45PM EDT

04:45 Thursday, August 27, 2020

|BEGINSUB|Asian Shares Mixed Ahead Of Powells Speech|ENDSUB|Asian stocks ended mixed on Thursday as geopolitical concerns returned to the fore and investors waited for Fed Chairman Jerome Powell's speech at the annual central bankers' conference later in the day for clues about whether a shift to easier policy is possible in the coming months.

|BEGINSUB|European Markets Close Weak Despite Coming Off Lower Levels|ENDSUB|European stocks ended on a negative note on Thursday, despite staging a fairly good recovery from lower levels during the closing hours after the Federal Reserve Chairman Jerome Powell outlined historic changes to Fed's monetary policy strategy.

|BEGINSUB|Dow, S&P 500 Rise Following Powell Speech, Nasdaq Closes Lower|ENDSUB|Stocks fluctuated over the course of the trading session on Thursday but largely maintained a positive bias. The S&P 500 reached a new record closing high and the Dow ended the day at its best closing level in over six months, although the tech-heavy Nasdaq eventually ended the day in the red.

|BEGINSUB|Stock Alert: NetApp Up 6% As Quarterly Results Beat Estimates |ENDSUB|Shares of NetApp Inc. are rising more than 6 percent or $2.69 in Thursdays morning trade at $44.90, after the cloud storage software companys quarterly results beat estimates.

Wednesday, NetApp reported first-quarter net income of $77 million or $0.35 per share, down from $103 million or $0.42 per share last year. However, adjusted earnings of $0.73 per share topped the consensus estimate of analysts polled by Thomson Reuters of $0.41 per share.

|BEGINSUB|Stock Alert: Quidel Tumbles 34% |ENDSUB|Shares of Quidel Corp (TS:QDEL) are losing more than 34 percent or $76.60 in Thursdays morning trade at $146.34.

Quidel is a developer of diagnostic testing solutions and already markets COVID-19 antigen tests. In May, the FDA issued the authorization to market Quidel's Sofia 2 SARS Antigen FIA, a rapid point-of-care test to be used with the Sofia 2 Fluorescent Immunoassay Analyzer for the rapid detection of SARS-CoV-2.

|BEGINSUB|Stock Alert: Moxian Touches New 52-week High On Merger News |ENDSUB|Shares of Moxian Inc. (MOXC) are rising more than 21 percent or $0.45 in Thursdays morning trade at $2.57, after earlier touching a new 52-week high of $3.44 as the China-based social networking platform operator agreed to merger terms with Btab Group Inc.

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2008 RealTimeTraders.com, Inc. All Rights Reserved